secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2023-02-09T23:59:59+00:00
Accession:  0001213900-23-009738
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Healthcare Q4 net income $2.8M ($0.17 EPS); FY22 revenue up 65% to $44.5M
--------------------------------------------------------------------------------

- Q4 2022 revenue $13.1M flat YoY; net income $2.8M ($0.17 diluted EPS) vs $5.3M ($0.32).
- Full-year revenue $44.5M (+65% YoY); cash $25.5M, no debt; adjusted EBITDA $4.3M vs $5.6M.
- Gross margin fell to 63.7% from 68.0% on higher manufacturing costs and inflation.
- Expects continued topline growth in Q1 2023 and full-year profitability; multiple 510(k) submissions planned in 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000121390023009738/0001213900-23-009738-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000121390023009738/ea172985-8k_sensus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-009738

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer